
265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market
The Readout Loud
00:00
Novak's Warning About Gavi Going Concern
The last thing I want is to be in a position of little or no leverage. So what I'm doing right now with our leadership team and our board is building that leverage, putting the muscle on so we can be really strong," he said. Gavi had paid Novak's for advanced purchase agreements of the COVID vaccine and has said Novak's wouldn't meet its commitment to deliver doses in 2022.
Transcript
Play full episode